AffiAB® Anti-FABP4 Antibody [JM10-99]
Fatty acid-binding proteins, designated FABPs, are a family of homologous, cytoplasmic proteins that are expressed in a highly tissue-specific manner and play an integral role in the balance between lipid and carbohydrate metabolism. FABPs mediate fatty acid (FA) and/or hydrophobic ligand uptake, transport, and targeting within their respective tissues. The mechanisms underlying these actions can give rise to both passive diffusional uptake and protein-mediated transmembrane transport of FAs. FABPs are expressed in adipocytes (A-FABP) , brain (B-FABP) , epidermis (E-FABP, also designated psoriasis-associated FABP or PA-FABP) , muscle and heart (H-FABP, also designated mammary-derived growth inhibitor or MDGI) , intestine (I-FABP) , liver (L-FABP) , myelin (M-FABP) and testis (T-FABP) . The human A-FABP gene is organized into 4 exons, maps to chromosome 8q21, and encodes a 132-amino acid protein. A-FABP protein comprises approximately 1% of the total cytosolic protein in human adipose tissue.
Antibody type
Recombinant Rabbit monoclonal Antibody
Uniprot ID
SwissProt: P15090 Human; SwissProt: P04117 Mouse; SwissProt: P70623 Rat
Recombinant
YES
Conjugation
Non-conjugated
Host
Rabbit
Isotype
IgG
Clone
JM10-99
KO/KD
N/A
Species reactivity
Human, Mouse, Rat
Tested applications
WB, IF-Cell, IF-Tissue, IHC-P
Predicted species reactivity
N/A
Immunogen
Synthetic peptide within human FABP4 aa 60-100.
Storage
Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Form
Liquid
Storage buffer
1*TBS (pH7.4) , 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration
1 mg/mL.
Purity
Protein A affinity purified.
Signal pathway
PPAR signaling pathway, Cardiovascular
Recommended dilutions
WB: 1:500-1:2, 000; IF-Cell: 1:100-1:500; IF-Tissue: 1:100-1:500; IHC-P: 1:50-1:500
Molecular Weight
15 kDa
Subcellular location
Nucleus. Cytoplasm.
Positive control
Mouse heart tissue lysates, MCF-7, A549, PMVEC, human breast tissue, mouse lung tissue.